Glynis Reede supports healthcare organizations with research and analysis on a wide range of health policy issues.
Before joining Avalere, Glynis served as an analyst at a boutique healthcare advisory firm where she researched and wrote about Medicaid, biosecurity, artificial intelligence in healthcare, hospitals, hospital payment rules, and the 2024 elections. She also researched and analyzed private equity’s effects on rural hospitals and organizations throughout the United States.
Glynis holds a bachelor’s degree in politics & international affairs, art history and bioethics, humanities, and medicines from Wake Forest University where she graduated Magna Cum Laude.
Authored Content
Stakeholders consider implementation of a 340B rebate model to address duplicate discount risk.
Sixty-nine percent of 340B contract pharmacies were associated with a PBM through vertical integration (53%) or contractual arrangement (16%).
With key health policy differences between presidential candidates, the 2024 elections are an inflection point for the future of US healthcare.